Pioglitazone HCL 30 MG tablet 500S
Ended Awarded Last action
- Contract number
- SPE2DR26FV8QN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,289
Award facts
- Contract value 100% obligated
- $1,289.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,289.05 to AmerisourceBergen Drug Corp for Pioglitazone HCL 30 mg tablets (500-count package) on December 9, 2025, with completion scheduled for December 10, 2025. This contract utilized firm fixed-price pricing with no set-aside designation, indicating open competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in Conshohocken, PA 19428. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026.
The SPE2DX vehicle serves as a comprehensive global pharmaceutical support contract enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. Pioglitazone HCL is a diabetes management medication, consistent with AmerisourceBergen's extensive portfolio of therapeutic pharmaceuticals delivered through DLA's Medical Supply Chain, which serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The non-set-aside competitive award reflects AmerisourceBergen's established capability to meet federal procurement requirements across the full spectrum of military medical supply needs.
Quick answers
Who was awarded contract SPE2DR26FV8QN?
SPE2DR26FV8QN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26FV8QN worth?
The government has obligated $1,289 on SPE2DR26FV8QN.
Is contract SPE2DR26FV8QN an order under another contract?
Yes. SPE2DR26FV8QN is a delivery order under SPE2DR25D7056, an indefinite delivery contract.
Was contract SPE2DR26FV8QN competed?
The extent of competition for SPE2DR26FV8QN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award